article thumbnail

Examining Current Challenges in Parenteral Nutrition Compounding

Drug Topics

Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.

article thumbnail

Implementing a Longitudinal Sterile Compounding Rotation for Pharmacy Residents

Pharmacy Times

This manuscript will describe the creation and development of a longitudinal sterile compounding rotation at an academic medical center for postgraduate year 1 acute care pharmacy residents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Importance of Continuing Education in Pharmacy Compounding

Drug Topics

Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.

article thumbnail

Novo Nordisk settles with 2 Florida sellers of compounded Ozempic

Fierce Pharma

Novo Nordisk has reached confidential settlements with two Florida sellers of compounded versions of the mega-blockbuster semaglutide treatments Ozempic and Wegovy, the company said on Friday.

article thumbnail

Clearmind licenses psychedelic compounds for mental disorders

Pharmaceutical Technology

psychedelic compounds for mental disorders. Clearmind Medicine has entered into a licensing agreement with Yissum to develop Generation 3.0

article thumbnail

Is Compounding Pharmacy Right For You?

The Happy PharmD

Are you considering a career in compounding pharmacy? Let me take you on a journey into the world of compounding pharmacists, where we dive into everything from job satisfaction to salary expectations. In terms of demand, the future looks promising for compounding pharmacists.

article thumbnail

Preserving Patient Access to Compounded Medications Act of 2017

Pharmacy Times

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.